Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage
Authors:
- Kurt T. BarnhartKBKurt T. Barnhart
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 83 (2) , 376-382
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Methotrexate and misoprostol used alone or in combination for early abortionContraception, 1999
- Is curettage needed for uncomplicated incomplete spontaneous abortion?American Journal of Obstetrics and Gynecology, 1998
- Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexateAmerican Journal of Obstetrics and Gynecology, 1998
- Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancyThe Lancet, 1997
- Efficacy of frozen-section evaluation of uterine curettings in the diagnosis of ectopic pregnancyAmerican Journal of Obstetrics and Gynecology, 1996
- Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experienceAmerican Journal of Obstetrics and Gynecology, 1996
- Prognostic factors for successful expectant management of ectopic pregnancyFertility and Sterility, 1995
- Expectant management of first-trimester spontaneous abortionThe Lancet, 1995
- Single-dose methotrexate: An expanded clinical trialAmerican Journal of Obstetrics and Gynecology, 1993
- Complications from Legally-Induced AbortionObstetrical & Gynecological Survey, 1979